Works matching IS 02683369 AND DT 2000 AND VI 26 AND IP 5

Results: 22

A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin’s disease or non-Hodgkin’s lymphoma.

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 471, doi. 10.1038/sj.bmt.1702531

By:

Stiff, P;
Gingrich, R;
Luger, S;
Wyres, M R;
Brown, R A;
LeMaistre, C F;
Perry, J;
Schenkein, D P;
List, A;
Mason, J R;
Bensinger, W;
Wheeler, C;
Freter, C;
Parker, W R L;
Emmanouilides, C

Publication type:

Article

Autologous PBSCT in patients with cardiac amyloidosis.

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 588, doi. 10.1038/sj.bmt.1702551

By:

Stevens, J M;
Patton, W N;
Heaton, D C;
Spearing, R L;
Shaw, G;
Bowie, D;
Smyth, D;
Comenzo, R

Publication type:

Article

Flow cytometric detection of growth factor receptors in autografts and analysis of growth factor concentrations in autologous stem cell transplantation: possible significance for platelet recovery.

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 525

By:

Schiødt, I;
Jensen, C H;
Kjærsgaard, E;
Gaarsdal, E;
Nikolajsen, K;
Johnsen, H E

Publication type:

Article

Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 545, doi. 10.1038/sj.bmt.1702545

By:

Schultz, K R;
Nevill, T J;
Balshaw, R F;
Toze, C L;
Corr, T;
Currie, C J;
Strong, D K;
Keown, P A

Publication type:

Article

Epstein–Barr virus-negative high grade B cell lymphoma of donor origin developing 19 months after unrelated allogeneic bone marrow transplantation.

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 577, doi. 10.1038/sj.bmt.1702548

By:

Gomyo, H;
Murayama, T;
Kizaki, T;
Mizuno, I;
Kitaori, K;
Sao, H;
Tobinai, K;
Koizumi, T;
Imoto, S

Publication type:

Article

Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation.

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 533, doi. 10.1038/sj.bmt.1702535

By:

Serody, J S;
Berrey, M M;
Albritton, K;
O’Brien, S M;
Capel, E P;
Bigelow, S H;
Weber, D J;
Gabriel, D A;
Wiley, J M;
Schell, M J;
Gilligan, P H;
Shea, T C

Publication type:

Article

Kinetics of in vivo homing and recruitment into cycle of hematopoietic cells are organ-specific but CD44-independent.

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 559, doi. 10.1038/sj.bmt.1702536

By:

Oostendorp, R A J;
Ghaffari, S;
Eaves, C J

Publication type:

Article

Predictors of physical outcomes in pediatric bone marrow transplantation.

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 553, doi. 10.1038/sj.bmt.1702549

By:

Dobkin, P-L;
Poirier, R-M;
Robaey, P;
Bonny, Y;
Champagne, M;
Joseph, L

Publication type:

Article

Ex vivo expansion of CD34-positive peripheral blood progenitor cells from patients with non-Hodgkin’s lymphoma: no evidence of concomitant expansion of contaminating bcl2/JH-positive lymphoma cells.

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 497, doi. 10.1038/sj.bmt.1702539

By:

Yao, Ming;
Fouillard, L;
Lemoine, F M;
Bouchet, S;
Firat, H;
Andreu, G;
Gorin, N C;
Douay, L;
Lopez, M

Publication type:

Article

Docetaxel effectively mobilizes peripheral blood CD34+ cells.

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 483, doi. 10.1038/sj.bmt.1702540

By:

Prince, H M;
Toner, G C;
Seymour, J F;
Blakey, D;
Gates, P;
Eerhard, S;
Chapple, P;
Wall, D;
Quinn, M;
Juneja, S;
Wolf, M;
Januszewicz, E H;
Richardson, G;
Scarlett, J;
Briggs, P;
Brettell, M;
Rischin, D

Publication type:

Article

A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 × 106 CD34+ cells/kg be considered the minimum threshold?

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 489, doi. 10.1038/sj.bmt.1702542

By:

Singhal, S;
Powles, R;
Treleaven, J;
Kulkarni, S;
Sirohi, B;
Horton, C;
Millar, B;
Shepherd, V;
Tait, D;
Saso, R;
Rowland, A;
Long, S;
Mehta, J

Publication type:

Article

Clinical impact of ex vivo differentiated myeloid precursors after high-dose chemotherapy and peripheral blood progenitor cell rescue.

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 505, doi. 10.1038/sj.bmt.1702543

By:

Zimmerman, T M;
Lee, W J;
Bender, J G;
Schilling, M;
Smith, S L;
Van Epps, D E;
Williams, S F

Publication type:

Article

Early viral complications after autologous CD34-selected peripheral blood stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 587, doi. 10.1038/sj.bmt.1702550

By:

Sica, S;
Sora, F;
Chiusolo, P;
Laurenti, L;
Cattani, P;
Giordano, G;
Piccirillo, N;
Ortu La Barbera, E;
Leone, G

Publication type:

Article

Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy.

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 539, doi. 10.1038/sj.bmt.1702546

By:

Lewis, I D;
DeFor, T;
Weisdorf, D J

Publication type:

Article

Histologic transformation of follicular lymphoma after allogeneic bone marrow transplantation.

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 581, doi. 10.1038/sj.bmt.1702547

By:

Kojima, K;
Mannami, T;
Yoshino, T;
Kawasaki, H;
Sasaki, K;
Maeda, T;
Furuya, K;
Harada, M;
Hara, M

Publication type:

Article

Cytotoxic T lymphocyte precursor frequency as a predictor of acute graft-versus-host disease in bone marrow transplantation from HLA-identical siblings.

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 517, doi. 10.1038/sj.bmt.1702553

By:

Affaticati, P;
Locatelli, F;
Roggero, S;
Marmont, F;
Falda, M;
Dall’Omo, A M;
Busca, A;
Ceretto, C;
Praticò, L;
Berrino, M;
Curtoni, E S

Publication type:

Article

Donor leukocyte infusions in acute lymphocytic leukemia.

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 511, doi. 10.1038/sj.bmt.1702555

By:

Collins, Jr., R. H.;
Goldstein, S.;
Giralt, S.;
Levine, J.;
Porter, D.;
Drobyski, W.;
Barrett, J.;
Johnson, M.;
Kirk, A.;
Horowitz, M.;
Parker, P.

Publication type:

Article

Wolman disease successfully treated by bone marrow transplantation.

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 567, doi. 10.1038/sj.bmt.1702557

By:

Krivit, W;
Peters, C;
Dusenbery, K;
Ben-Yoseph, Y;
Ramsay, N K C;
Wagner, J E;
Anderson, R

Publication type:

Article

Peripheral stem cell transplantation in a child with amegakaryocytic thrombocytopenia.

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 571

By:

Yeşilipek, M A;
Hazar, V;
Küpesiz, A;
Yeğin, O

Publication type:

Article

Donor lymphocyte infusion for treatment of life-threatening respiratory syncytial virus infection following bone marrow transplantation.

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 573, doi. 10.1038/sj.bmt.1702559

By:

Kishi, Y;
Kami, M;
Oki, Y;
Kazuyama, Y;
Kawabata, M;
Miyakoshi, S;
Morinaga, S;
Suzuki, R;
Mori, S;
Muto, Y

Publication type:

Article

Searching for a cord blood unit for transplantation based on the unit’s cell count.

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 585, doi. 10.1038/sj.bmt.1702560

By:

Bleakley, M;
Shaw, P J

Publication type:

Article

Individualizing high-dose oral busulfan: prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hematologic malignancies.

Published in:

Bone Marrow Transplantation, 2000, v. 26, n. 5, p. 463, doi. 10.1038/sj.bmt.1702561

By:

Tran, H T;
Madden, T;
Petropoulos, D;
Worth, L L;
Felix, E A;
Sprigg-Saenz, H A;
Choroszy, M;
Danielson, M;
Przepiorka, D;
Chan, K-W

Publication type:

Article

Works matching IS 02683369 AND DT 2000 AND VI 26 AND IP 5

A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin’s disease or non-Hodgkin’s lymphoma.

Autologous PBSCT in patients with cardiac amyloidosis.

Flow cytometric detection of growth factor receptors in autografts and analysis of growth factor concentrations in autologous stem cell transplantation: possible significance for platelet recovery.

Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.

Epstein–Barr virus-negative high grade B cell lymphoma of donor origin developing 19 months after unrelated allogeneic bone marrow transplantation.

Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation.

Kinetics of in vivo homing and recruitment into cycle of hematopoietic cells are organ-specific but CD44-independent.

Predictors of physical outcomes in pediatric bone marrow transplantation.

Ex vivo expansion of CD34-positive peripheral blood progenitor cells from patients with non-Hodgkin’s lymphoma: no evidence of concomitant expansion of contaminating bcl2/JH-positive lymphoma cells.

Docetaxel effectively mobilizes peripheral blood CD34<sup>+</sup> cells.

A low CD34<sup>+</sup> cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 × 10<sup>6</sup> CD34<sup>+</sup> cells/kg be considered the minimum threshold?

Clinical impact of ex vivo differentiated myeloid precursors after high-dose chemotherapy and peripheral blood progenitor cell rescue.

Early viral complications after autologous CD34-selected peripheral blood stem cell transplantation.

Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy.

Histologic transformation of follicular lymphoma after allogeneic bone marrow transplantation.

Cytotoxic T lymphocyte precursor frequency as a predictor of acute graft-versus-host disease in bone marrow transplantation from HLA-identical siblings.

Donor leukocyte infusions in acute lymphocytic leukemia.

Wolman disease successfully treated by bone marrow transplantation.

Peripheral stem cell transplantation in a child with amegakaryocytic thrombocytopenia.

Donor lymphocyte infusion for treatment of life-threatening respiratory syncytial virus infection following bone marrow transplantation.

Searching for a cord blood unit for transplantation based on the unit’s cell count.

Individualizing high-dose oral busulfan: prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hematologic malignancies.